Prospective, Randomized (1:1), Double-Blind, Parallel-Group, Active-Controlled, Multicenter Study to Compare Safety and Efficacy of Smoflipid to Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age Requiring Parenteral Nutrition for at Least 90 Days and up to 1 Year
Latest Information Update: 31 Jan 2020
At a glance
- Drugs Soya oil emulsion/medium-chain triglyceride/olive oil/fish oil (Primary) ; Soya oil emulsion
- Indications Malnutrition
- Focus Adverse reactions; Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- Sponsors Fresenius Kabi
- 27 Jan 2020 Status changed from not yet recruiting to recruiting.
- 02 Sep 2019 Planned initiation date changed from 31 Jul 2019 to 30 Sep 2019.
- 09 Jul 2019 Planned initiation date changed from 1 May 2019 to 31 Jul 2019.